Currently, initial products with a high strategic importance to Symrise are being worked on in the New Haven, CT labs of P2. Products of immediate commercial interest to both companies are expected to be scaled up to production for commercial supply within a 12-month timeframe. Brand new molecules will be assessed for toxicology, performance and economics. Selected products will be moved through a commercialization process for use in certain Symrise end markets and potential sale to other flavor and fragrance companies.
P2 Science is a venture-backed company, using patent pending hybrid ozonlysis technology to convert biomass into specialty chemicals.